TORONTO, June 21, 2019 /CNW/ - Akumin Inc.
("Akumin" or the "Corporation") (TSX: AKU.U; AKU)
held its annual meeting of shareholders (the "Meeting") in
Toronto, Ontario on June 21, 2019. A total of 36,006,512 shares,
representing approximately 57.42% of shares outstanding, were
represented in person or by proxy.
Further to TSX reporting requirements, the voting in relation to
the election of directors was conducted at the Meeting and the
results were as follows:
|
Nominee
|
Votes
For
|
Votes
Withheld
|
Not
Voted
|
|
#
|
#
|
#
|
|
Thomas
Davies
|
35,956,333
(100.000%)
|
0 (0.000%)
|
2,560
|
|
Stan
Dunford
|
35,956,333
(100.000%)
|
0 (0.000%)
|
2,560
|
|
Murray Lee
|
33,146,393
(92.185%)
|
2,809,940
(7.815%)
|
2,560
|
|
James Webb
|
35,956,333
(100.000%)
|
0 (0.000%)
|
2,560
|
|
Riadh Zine
|
35,956,333
(100.000%)
|
0 (0.000%)
|
2,560
|
The appointment of the auditors, as described in the Company's
management information circular dated May
20, 2019, was duly approved by the requisite number of
votes.
About Akumin
Akumin is a leading provider of freestanding, fixed-site
outpatient diagnostic imaging services in the United States with a network of owned
and/or operated imaging centers located in Florida, Texas, Pennsylvania, Delaware, Georgia, Illinois and Kansas. By combining our clinical expertise
with the latest advances in technology and information systems, our
centers provide physicians with imaging capabilities to facilitate
the diagnosis and treatment of diseases and disorders and may
reduce unnecessary invasive procedures, minimizing the cost and
amount of care for patients. Our imaging procedures include MRI,
CT, positron emission tomography (PET), ultrasound, diagnostic
radiology (X-ray), mammography, and other interventional
procedures.
SOURCE Akumin Inc.